Alx Oncology Holdings Inc (ALXO) saw an uptrend of 8.76% in the recent trading with $0.55 being its most recent. The current price level -96.94% lower than the highest price of $17.83 marked by the stock while trading over the past 52-weeks, whereas it is 18.52% higher than the lowest price of $0.46 the company dropped to over past 52-weeks. The latest news story on ALXO appeared in (GlobeNewswire) under the title “ALX Oncology Receives IND Clearance from U.S. FDA for ALX2004, a Novel EGFR-targeted Antibody-drug Conjugate”.
Squeezing the time span to 30 day period shows us the stock is currently trading -37.33% below one month high and is +18.52% above of the lowest during that time. Looking into the simple moving average, Alx Oncology Holdings Inc (ALXO)’s stock stands at a SMA-50 of $0.8741 while that of 5-day is reading $0.5070.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and ALXO’s SMA-200 as of now is $2.1009.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 5 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.33 for the stock.
Alx Oncology Holdings Inc Earnings – What Happened With ALXO
Coming around sales and income figures on ALXO Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
ALXO – Alx Oncology Holdings Inc Stock Earnings Estimates
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 53.05 million. ALXO does have institutional investors; and they hold 56.29% of the stock.
Alx Oncology Holdings Inc – Insider Activity and Holdings
As on 2024-06-30, VENBIO PARTNERS LLC was the top most holder in Alx Oncology Holdings Inc (NASDAQ:ALXO) with an ownership of 9.7 million shares of the company or 18.7145 of the stake worth $58.49 million. The filing also reveals FMR LLC as the second largest holder in the company with a control over 15.0778 of the outstanding shares. Its stake is worth $47.12 million for having 7.81 million shares in hand.
VIVO CAPITAL, LLC also came holding a key position in the company during the recent quarter and it now holds 8.1419 of the outstanding shares. With this there are now 127.0 institutions which have possession in ALXO’s shares.
Currently, the stock has been recommended as Strong Buy by 5 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.33 for the stock.
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Alx Oncology Holdings Inc has a debt to equity ratio of 0.15.
Technical Analysis of Alx Oncology Holdings Inc (NASDAQ:ALXO) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Alx Oncology Holdings Inc (ALXO), we notice that the stock’s 20-day average volume is at 523,870 shares and 100% of short term indicators are suggesting the stock as Sell. Medium term indicators at an average of 100% are spotting the stock at Sell with its 50-day average volume of 884,656 shares. And to end, ALXO’s 100-day average volume is 1,045,905 shares with 100% of the long-term indicators pointing towards Sell for the stock.
